Cargando…
Protective effects of PACAP in ischemia
Pituitary adenylate cyclase activating polypeptide (PACAP) is an ubiquitous peptide involved, among others, in neurodevelopment, neuromodulation, neuroprotection, neurogenic inflammation and nociception. Presence of PACAP and its specific receptor, PAC1, in the trigeminocervical complex, changes of...
Autores principales: | Reglodi, Dora, Vaczy, Alexandra, Rubio-Beltran, Eloísa, MaassenVanDenBrink, Antoinette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834414/ https://www.ncbi.nlm.nih.gov/pubmed/29500688 http://dx.doi.org/10.1186/s10194-018-0845-3 |
Ejemplares similares
-
PACAP38 and PAC(1) receptor blockade: a new target for headache?
por: Rubio-Beltrán, Eloisa, et al.
Publicado: (2018) -
The Protective Effects of Endogenous PACAP in Oxygen-Induced Retinopathy
por: Kvarik, Timea, et al.
Publicado: (2021) -
Gender aspects of CGRP in migraine
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017) -
Distribution of PACAP and PAC1 Receptor in the Human Eye
por: Patko, Evelin, et al.
Publicado: (2022) -
Retinoprotective Effects of PACAP Eye Drops in Microbead-Induced Glaucoma Model in Rats
por: Szabo, Edina, et al.
Publicado: (2021)